Gri Bio, INC DEF 14A proxy statements

GRI Bio, Inc. is seeking stockholder approval for a reverse stock split to address Nasdaq listing deficiencies and avoid potential delisting.

GRI Bio, Inc. announced its 2025 Annual Meeting of Stockholders will be held virtually on August 13, 2025, seeking approval for director elections, auditor ratification, and a significant increase in shares available for its equity incentive plan.

GRI Bio is asking stockholders to approve a reverse stock split to meet Nasdaq's minimum bid price requirement and avoid potential delisting.

GRI Bio, Inc. adjourned its Annual Meeting to September 6, 2024, to solicit additional proxies for the remaining proposals.

GRI Bio adjourned its Annual Meeting to September 6, 2024, to solicit additional proxies for remaining proposals after confirming the adjournment proposal was approved and a quorum was present.

GRI Bio, Inc. has engaged Campaign Management, LLC to solicit proxies for its upcoming Annual Meeting of Stockholders on August 23, 2024.

GRI Bio is asking stockholders to approve the issuance of shares underlying certain warrants and an amendment to its equity incentive plan at the upcoming annual meeting.

GRI Bio is asking stockholders to approve a reverse stock split to meet Nasdaq's minimum bid price requirement and maintain its listing.